Leif Niclas Fredrik Löwgren
Director/Board Member en Omnivation AB .
Perfil
Leif Niclas Fredrik Löwgren is currently a Director at Omnivation AB.
He was previously a Director at Copperstone Resources AB, QuiaPEG Pharmaceuticals AB, NextCell Pharma AB, and Quiapeg Pharmaceuticals Holding AB.
Mr. Löwgren holds an MBA from the University of Stockholm.
Cargos activos de Leif Niclas Fredrik Löwgren
Empresas | Cargo | Inicio |
---|---|---|
Omnivation AB | Director/Board Member | - |
Antiguos cargos conocidos de Leif Niclas Fredrik Löwgren.
Empresas | Cargo | Fin |
---|---|---|
COPPERSTONE RESOURCES AB | Director/Board Member | 14/05/2019 |
NEXTCELL PHARMA AB | Director/Board Member | - |
QUIAPEG PHARMACEUTICALS HOLDING AB | Director/Board Member | - |
QuiaPEG Pharmaceuticals AB
QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Director/Board Member | - |
Formación de Leif Niclas Fredrik Löwgren.
University of Stockholm | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
COPPERSTONE RESOURCES AB | Non-Energy Minerals |
NEXTCELL PHARMA AB | Health Technology |
QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
Empresas privadas | 2 |
---|---|
QuiaPEG Pharmaceuticals AB
QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Health Technology |
Omnivation AB |
- Bolsa de valores
- Insiders
- Leif Niclas Fredrik Löwgren